• Journal of Korean Neurosurgical Society
• /
• 제47권4호
• /
• pp.282-286
• /
• 2010

Objective : The aim of the present study was to assess the effect of lumbar disc herniation surgery for low back pain on the erectile functioning. Methods : Thirty-eight patients, with age ranging from 22 to 56 years, who had presented with pain due to herniated lumbar discs were included in the study. International Index of Erectile Function (IIEF) Short Form questionnaire was used to evaluate the erectile functioning. Patient visits on the 1st week,1st month and 3rd month postoperatively were analyzed. Pain scores were also noted together with side effects and the complications of the surgery. Results : Of the 38 patients, 18 patients had reported erectile dysfunction; 10 patients mild and 8 patients moderate erectile dysfunction. Twenty patients did not report erectile problems. The herniation levels mostly were L5-S1 in 12 (31.6%). Overall, erectile dysfunction rates have improved in 31.7% of those previously with erectile dysfunction in a 3 month period after the surgery. Best results were obtained in those patients with mild erectile dysfunction preoperatively. Conclusion : Mild erectile dysfunction together with radiculopathy tends to improve after lumbosacral disc surgery. Moderate and severe erectile dysfunction may be related to a more severe nerve injury or to vascular and/or psychiatric factors. An evaluation of erectile functioning should routinely be performed in patients with lumbosacral disc disease both for data accumulation and for medico legal causes since the documentation of the correlation between erectile dysfunction and lumbosacral disc disease is still lacking.

• 대한한방내과학회지
• /
• 제22권4호
• /
• pp.527-535
• /
• 2001

Objectives : To improve decreased erectile function as well as impotence, caused by physical fatigue, psychologic stress, too much alcohol and smoking, medication like antihypertensives, and geriatric change, by the prescription of BOWONDAN. Methods : 18 male-volunteers with decreased erectile function who are married 30 to 59 years old, were studied about the difference of a sexual function between before and after taking BOWONDAN 3 pills a day for a month. The results of IIEF(International Index of Erectile Function) and AVSS(Audio-Visual Sexual Stimulation) were reviewed statistically with paired samples t-test. Results : Based on the IIEF, 13(81.25%, p<0.01), 9(56.25%, p<0.05), 9(56.25%, p<0.05), 9(56.25%, p<0.05), 7(43.75%, p<0.05) and 15(93.75%, p<0.01) volunteers were improved in erectile function, orgasmic function, sexual desire, intercourse satisfaction, overall satisfaction and total score respectively, among 16 volunteers excluding 2 due to a false measurement. Through the Rigiscan of AVSS, 11 (68.75%, p<0.1)volunteers were improved in base tumescence, among 16 volunteers excluding 2 due to a false measurement. Conclusions : As a result of our work, BOWONDAN is expected to take effect to treat or improve both impotence and decreased erectile function.

• 임상간호연구
• /
• 제20권3호
• /
• pp.290-302
• /
• 2014

Purpose: The purpose of this study was to identify sexual activities of males with spinal cord injury (SCI) and influential factors of sexual adjustment. Methods: A correlational survey was conducted among a total of 135 males with SCI. Results: After SCI, patients maintained low levels of sexual adjustment, and a main obstacle of sexual rehabilitation was decreased erectile function (65.2%). Sexual desires recovered in 84.4%, with 62.4% patients reporting more than once intercourse experiences. The erectile function of participants with normal, decreased or no erectile function were 13.0%, 62.6% and 24.4%, respectively. 8.1% of the participants reported no problem with ejaculation. Patients with incomplete SCI had better preserved erectile function than those with complete SCI (t=-4.627, p<.001). Patients with upper motor neuron injury had better preserved erectile function than those with lower motor neuron injury (t=2.446, p =.016). Sexual adjustment was relevant to age, job, degree of injury, post-injury period, sexual desire, intercourse experience, erection therapy, erectile function, and sexual health. Sexual adjustment was a factor of sexual health with a power of 24.2%. Conclusion: The main obstacle of sexual rehabilitation for males with SCI decreased erectile function. Erection and ejaculation are dependent on the severity and level of SCI. The major influence on sexual adjustment is sexual health.

• 대한한방내과학회지
• /
• 제25권2호
• /
• pp.258-267
• /
• 2004

Objective : This study investigated the effects of Yangsaengwhallyukdan on nitrite oxide synthase (NOS) activity, nitrite level, antioxidation and erectile response in rat corpus cavernosum penis. Methods : Yangsaengwhallyukdan was formulated to contain various natural products that have been used to treat erectile dysfunction. Yangsaengwhallyukdan suspended in a 0.5% CMC solution was oral-administered, 50 mg or 100 mg per 1 kg of body weight for 30 days, while the normal group was administered only with a 0.5% CMC solution. The efficacy of the Yangsaengwhallyukdan was assessed with regard to erectile function. Results: After the Yangsaengwhallyukdan was administered to the rat for 30 days, the urethral NOS activity increased. The level of urethral nitrite, glutathione and testosterone increased too. The level of urethral lipid peroxide was decreased in Yangsaengwhallyukdan treated rats. The erectile response to a cavernous nerve stimulation in L-NAME$(10^4)$-treated rats in rats given Yangsaengwhallyukdan reached the level of the normal group. Conclusions : This study suggest that Yangsaengwhallyukdan is effective for the treatment of erectile dysfunction.

• Molecules and Cells
• /
• 제41권6호
• /
• pp.553-561
• /
• 2018

Icariside II (ICA II) is used in erectile dysfunction treatment. Adipose tissue-derived stem cells (ADSCs) are efficient at improving erectile function. This study aimed to explore the action mechanism of ADSCs in improving erectile function. ADSCs were isolated from the adipose tissues of rats. Cell proliferation was determined using the Cell Counting Kit-8 (CCK-8) assay. The expressions of mRNA and protein were determined separately through qRT-PCR and western blot. The endogenous expressions of related genes were regulated using recombinant plasmids and cell transfection. A Dual-Luciferase Reporter Assay was performed to determine the interaction between miR-34a and STAT3. Rat models with bilateral cavernous nerve injuries (BCNIs) were used to assess erectile function through the detection of mean arterial pressure (MAP) and intracavernosal pressure (ICP). ICA II promoted ADSCs' proliferation and differentiation to Schwann cells (SCs) through the inhibition of miR-34a. Suppressed miR-34a promoted the differentiation of ADSCs to SCs by upregulating STAT3. ICA II promoted the differentiation of ADSCs to SCs through the miR-34a/STAT3 pathway. The combination of ICA II and ADSCs preserved the erectile function of the BCNI model rats. ADSCs treated with ICA II markedly preserved the erectile function of the BCNI model rats, which was reversed through miR-34a overexpression. ICA II promotes the differentiation of ADSCs to SCs through the miR34a/STAT3 pathway, contributing to erectile function preservation after the occurrence of a cavernous nerve injury.

• 대한약침학회지
• /
• 제27권2호
• /
• pp.82-90
• /
• 2024

Objectives: Nitric oxide is the most important mediator of penile erection after the onset of sexual excitement. It activates cyclic guanosine monophosphate (cGMP), increasing penile blood flow. Most pharmaceutical medications prevent enzyme phosphodiesterase type 5 (PDE-5) from breaking down cGMP, thus keeping its level high. However, due to the adverse effects of pharmacological therapies, herbal drugs that improve sexual function have gained attention recently. This study aimed to investigate the combined effects of ginseng, Tribulus terrestris, and L-arginine amino acid on the sexual performance of individuals with erectile dysfunction (ED) using the 5-item version of the International Index of Erectile Function (IIEF-5) questionnaire. Methods: Over three months, 98 men with erectile dysfunction were randomly assigned to receive either 500 mg of herbal supplements or placebo pills. Each herbal tablet contained 100 mg of protodioscin, 35 mg of ginsenosides, and 250 mg of L-arginine. Results: The results showed that the changes in the average scores of ILEF-5 within each group before and after the intervention indicated that all parameters related to the improvement of sexual function in patients with erectile dysfunction improved in the herbal treatment group (p < 0.001). The herbal group significantly improved IIEF-5 scores in nondiabetics (p < 0.05). However, there was no significant difference in the changes of IIEF-5 scores between the two intervention and control groups in diabetic patients. Conclusion: In conclusion, ginseng, Tribulus terrestris, and L-arginine have properties that increase energy and strengthen sexual function, making them suitable for patients with sexual disorders.

• 한국자원식물학회지
• /
• 제31권2호
• /
• pp.109-116
• /
• 2018

발기부전(erectile dysfunction, impotence)은 성교과정을 위한 음경이 딱딱하게 발기되지 않거나 유지하지 못하는 것을 말한다. 잦은 발기 부전은 심장 질환, 비만, 알코올 중독, 스트레스, 흡연 및 우울증을 비롯하여 치료가 필요한 건강상의 문제가 원인이 된다. 본 연구는 산수유(Cornus officinalis)를 포함한 복합 추출물이 발기부전 랫드모델에서 성기능과 관련된 인자에 미치는 영향을 알아보고자 하였다. 발기부전 랫드모델은 Cimetidine/5% EtOH를 2주 동안 경구투여하여 유도한 후, 산수유 등 복합추출물을 각각 다른 농도로 경구투여하였다. 그 결과, 산수유 등 복합추출물 처리군(CPL-300, 600, 900 mg/kg)에서 성 기능 인자(NO, cGMP)가 대조군에 비해 유의성 있게 향상되었다. 또한 혈청 테스토스테론은 산수유 등 복합추출물 처리 후 용량 의존적으로 증가하였다. 더욱이, 산수유 등 복합추출물의 투여는 발기부전 랫드모델에서 전립선의 크기를 회복시키는 것을 확인하였다. 결과를 종합하자면 산수유 등 복합추출물이 랫드모델에서 성기능 인자와 테스토스테론을 증가시킴으로써 발기부전을 완화시킨다는 것을 보여 주었고, 이는 산수유 등 복합추출물이 천연 추출물로 향 후 발기부전 치료에 사용될 수 있음을 시사한다. 하지만 산수유 복합추출물의 남성 성기능의 직접적인 연관관계, 유효성분과 그 메커니즘을 자세히 밝히기 위해서는 추가적인 연구가 필요하다고 사료된다.

• 한국전자통신학회논문지
• /
• 제12권6호
• /
• pp.1197-1210
• /
• 2017

본 연구는 음경의 특성에 따른 조루증 및 발기능을 비교하고자 하였다. 99명의 성인 남성은 음경의 특성, 조루증, 발기능에 대한 설문조사에 응답하였다. 설문을 확인하는 과정에서 누락이 있거나 불완전한 응답을 제외한 69명의 설문을 분석하였다. 수집한 모든 데이터는 SPSS 22를 이용하여 독립 t 검정, 카이제곱 검정을 통하여 확인하였다. 연구 결과, 귀두가 음경보다 더 굵은 유형은 비슷한 유형과 비교하여 주관적 조루, 객관적 조루에서 유의한 차이가 있었다(p<.05). 주관적 조루인 자는 없는 자와 비교하여 객관적 조루, 치료의향, 성교 만족도에서 유의한 차이가 있었다(p<.05). 객관적 조루의 유무, 조루증 치료의향의 유무, 결혼 유무는 성교 만족도에서 유의한 차이가 있었다(p<.05). 경제 수준이 높은 자는 보통 또는 낮은 자와 비교하여 발기능 자신감에서 유의한 차이가 있었다(p<.05). 본 조사연구의 결과는 음경의 특성에 따른 조루 및 발기능은 차이를 나타낼 수 있음을 시사하며, 조루증과 발기능 장애가 있는 남성의 성기능 재활을 위한 중재 프로그램 개발의 기초자료로 사용될 수 있을 것이다.

• 생약학회지
• /
• 제38권1호
• /
• pp.50-55
• /
• 2007

This study was designed to investigate the effects KH-204 on erectile dysfunction in hyperlipidemic rat. KH-204 has been evaluated antihyperlipidemic and antierectile dysfunction effects on experimental hyperlipidemic rats induced by high fat diet. After oral administration of the water extract KH-204 (50, 100, 200, 300 mg/kg) to hyperlipidemic rats for 8 weeks, the variables including body weight, total cholesterol, HDL and LDL levels in serum, the expression of eNOS and nNOS in penis were measured. And erectile function was determined by measurement of intracavernosal pressure (ICP) and maximal arterial pressure (MAP) after electrical stimulation of the cavernosal nerve. Oral administration of KH-204 significantly inhibited the increases of serum total cholesterol and LDL-cholesterol levels and the decreased of serum HDL-cholesterol levels in hyperlipidemic rats induced by high fat diet. The penile expression level of the two enzyme (eNOS, nNOS) were increased significantly after oral administration of the KH-204 50 mg/kg. Erectile function after 10 volts stimulation was significantly decreased in the hyperlipidemic rat compared with the normal rat, but increased in KH-204 group compared with hyperlipidemic group. These results suggest that KH-204 is effective for erectile dysfunction in hyperlipidemia.

• Journal of Ginseng Research
• /
• 제25권3호
• /
• pp.112-117
• /
• 2001

발기부전 환자에서 홍삼의 치료효능을 평가하기 위하여 발기 능력을 측정하고 발기부전의 치료효과를 평가하기 위하여 개발되어 국제적으로 발기부전의 평가지표로 인정되고 있는 IIEF를 이용하여 시행한 연구 결과에서 발기력 강도와 유지의 일차 유효성 평가에서 위약군에 비하여 치료효과가 있는 것으로 나타났으며, 5개의 범주로 나누어 분석한 이차 유효성평가에서는 성적 욕구의 범주의 성욕의 빈도 및 성욕의 정도 항목과 성교 시도 횟수 항목을 제외한 모든 항목에서 홍삼 투여군에서 위약 투여군에 비해 통계학적으로 유의하게 높은 치료 효과를 나타내었다. 8주간 투약종료시범에서 치료가 대상환자에게 도움이 되었는가를 알아보는 유효성 평가 문항에서 홍삼 투여군은 58.3%(14/24)에서 도움이 되었다고 답변을 하여 위약 투여군의 26.1%(6/23)에 비하여 유의하게 높은 치료효과를 나타내었으며, 약물의 안정성 평가에서는 약물관련 특이 반응이나 특별한 부작용은 없는 것으로 나타났다. 이상으로 발기부전 환자에서 홍삼의 투여가 특별한 독성이나 부작용 없이 위약군에 비하여 좋은 치료효과를 보이는 것으로 나타났으며, 단독 투여뿐만 아니라 다른 발기부전 치료제와의 병용 요법에 따른 상승효과(synergic effect) 등에 대하여도 임상 연구가 필요하리라 생각된다.